Answers are grounded in this paper and cite their sources.
These results suggest clinical utility of non-invasive vagus nerve stimulation for migraine prevention, particularly for patients who have migraine with aura, and reinforce the well-established safety and tolerability profile of this therapy.Trial Registration: ClinicalTrials.gov (NCT03716505).
No takes yet. Share an insight, caveat, or question.
Najib et al. (2022) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: